Monashee Investment Management LLC Protagonist Therapeutics, Inc Transaction History

Monashee Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$12.95 - $49.69 $259,000 - $993,800	-20,000 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$25.57 - $44.88 $511,400 - $897,600	20,000 New	20,000 $898,000
Q1 2021 May 14, 2021	SELL	$19.02 - $31.15 $1.33 Million - $2.18 Million	-70,000 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$18.49 - $25.13 $1.29 Million - $1.76 Million	70,000 New	70,000 $1.41 Million
Q1 2019 May 13, 2019	SELL	$6.5 - $13.77 $279,142 - $591,352	-42,945 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$6.82 - $11.26 $292,884 - $483,560	42,945 New	42,945 $442,000

248

56.7M

76.3K

114K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $1.93B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.